Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Z. Obeidat, MD, PhD
High-Efficacy DMTs: Transforming MS Care
Long-Term Safety of DMTs: What We Know and What We Need to Know
Balancing Act: Immune Reconstitution vs Immune Suppression
From Pathology to Practice: The Role of Inflammation in MS Pathology
Fluid Biomarkers: Revolutionizing MS Diagnosis
Imaging Biomarkers: MS Progression in Focus
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Brain Health in MS: A Comprehensive Approach
PROs in MS: A New Era of Patient-Centric Care
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
James R. Bateman, MD, MPH
Jerome A. Barakos, MD
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
B. Joy Snider, MD, PhD
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Nilika Singhal, MD
M. Scott Perry, MD
Elizabeth Anne Thiele, MD, PhD
Novel Therapies to Manage OFF Episodes in Patients with Parkinson’s Disease
Robert A. Hauser, MD, MBA, FAAN
Stuart H. Isaacson, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.